Current Edition


New Analysis Shows High Rates of Skin Clearance as Measured by Absolute PASI in Patients With Moderate to Severe Plaque Psoriasis Treated With Janssen’s TREMFYA® (guselkumab)

Janssen-Cilag International NV (“Janssen”) presented a new analysis from VOYAGE 1 assessing efficacy responses based on absolute Psoriasis Area and Severity Index score (PASI), as …

Continue Reading →

Khondrion Presents Phase II KHENERGY Trial Data

Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, today announced results from its KHENERGY study, a Phase II exploratory …

Continue Reading →

Clinical placebo study confirms medical evidence for the Antinitus patch as a treatment method for tinnitus

The results of a recent clinical placebo study indicates significant and statistically assured positive effects of the Antinitus patch for reducing discomfort from tinnitus. As …

Continue Reading →